NGS-based RNA-seq Market by Products & Services (Sample Preparation, Consumables, Bioinformatics), Technology (SBS, SMRT), Application (De novo, Transcriptome Epigenetics, Small RNA), End User (Research Centers, BioPharma Companies) - Global Forecast to 2022


Report ID : RNR-78228 Category : Biotechnology Published Date : May 2017
Publisher : 9Dimen Pages : 156 Format : PDF
The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.

Market Segments
In 2016, the sequencing platforms and consumables segment is expected to account for the largest share of the market. The data analysis, storage, and management is expected to register the highest growth rate owing to its development of more efficient data analysis solutions and growing computational capabilities of data analytics providers. Research centers and academic & government institutes segment accounted for the largest share of the global market in 2016 due to the increasing focus of market players on providing efficient RNA-seq products & services for research applications and the growing number of government funding programs. However, the hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. Based on applications, the market is categorized into four segments, namely, de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing. The expression profiling analysis segment accounted for the major share of the global NGS-based RNA-seq market owing to the technological advantages of expression profiling applications.

Largest and Fastest Geographical Market 
Geographically, the NGS-based RNA-seq market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pasific. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, owing to focus on R&D activities and the low cost of NGS products & services in this region.

Breakdown of supply-side primary interviews: by company type, designation, and region: 
• By Company Type - Tier 1 – 33%, Tier 2 – 50% and Tier 3 – 17% 
• By Designation – C level – 35%, Director level – 25%, Others – 40% 
• By Region – North America - 24%, Europe – 19%, APAC – 33%, RoW – 24%

Growth Strategies
The global NGS-based RNA-seq market is highly competitive, with a large number of global and local players. In 2016, the market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.). Product launches, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market. 

Research Coverage
This report studies the NGS-based RNA-seq market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report: 
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS-based RNA-seq market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares. 

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the NGS-based RNA-seq market. The report analyzes the NGS-based RNA-seq market based on product & service, application, technology, end user, and region

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the NGS-based RNA-seq market 

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS-based RNA-seq products and services across geographies

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the NGS-based RNA-seq market

• Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the NGS-based RNA-seq market
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary And Primary Research Methodology
2.3.1 Secondary Research
2.3.1.1 Key Data From Secondary Sources
2.3.2 Primary Data
2.3.2.1 Key Data From Primary Sources
2.3.2.2 Key Industry Insights
2.4 Market Size Estimation
2.4.1.1 Bottom-up Approach
2.4.1.2 Top-down Approach
2.5 Market Breakdown And Data Triangulation
2.6 Assumptions For The Study
3 Executive Summary
3.1 Introduction
4 Premium Insights
4.1 Ngs-based Rna-seq Market Overview
4.2 Ngs-based Rna-seq Market Growth Rate, By Technology, 2017 Vs. 2022 (Usd Million)
4.3 Ngs-based Rna-seq Market, By Application And Region, 2017 (Usd Million)
4.4 Ngs-based Rna-seq Market, By End User, 2017 Vs. 2022
4.5 Geographical Snapshot Of The Ngs-based Rna-seq Market
?
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advantages Of Rna-seq Over Microarray Technology
5.2.1.2 Technological Advancements In Rna-seq Products
5.2.1.3 Increasing Number Of Rna-seq Grants
5.2.1.4 Increasing Number Of Research Activities Involving Rna-seq
5.2.1.5 Rapid Growth In Precision Medicine
5.2.2 Restraints
5.2.2.1 Lack Of Skilled Professionals
5.2.2.2 Standardization Concerns Of Rna-seq In Diagnostic Testing
5.2.3 Opportunities
5.2.3.1 Increasing Applications Of Rna-seq In Research
5.2.3.1.1 Cancer Research
5.2.3.1.2 Agricultural Research
5.2.4 Challenges
5.2.4.1 Storage & Interpretation Of Sequencing Data
5.2.4.2 Analysis Of Rna-seq Data For Detection Of Novel Transcripts
5.3 Industry Trends
5.3.1 Growing Number Of Strategic Partnerships And Collaborations
5.3.2 Increasing Number Of Conferences And Workshops Related To Rna-seq
6 Global Ngs-based Rna Sequencing Market, By Product & Service
6.1 Introduction
6.1.1 Sample Preparation
6.1.1.1 Sample Preparation, By Workflow Step
6.1.1.1.1 Fragmentation, End Repair, And Size Selection
6.1.1.1.2 Library Preparation And Target Enrichment
6.1.1.1.3 Quality Control
6.1.1.2 Sample Preparation, By Method
6.1.1.2.1 Manual Sample Preparation
6.1.1.2.2 Microfluidic Sample Preparation
6.1.1.2.3 Robotic Liquid Handling Sample Preparation
6.1.2 Sequencing Platforms And Consumables
6.1.3 Sequencing Services
6.1.4 Data Analysis, Storage, And Management
?
7 Global Ngs-based Rna Sequencing Market, By Technology
7.1 Introduction
7.2 Sequencing By Synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single-molecule Real-time Sequencing
7.5 Nanopore Sequencing
8 Global Ngs-based Rna Sequencing Market, By Application
8.1 Introduction
8.2 Expression Profiling Analysis
8.3 Small Rna Sequencing
8.4 De Novo Transcriptome Assembly
8.5 Variant Calling And Transcriptome Epigenetics
9 Global Ngs-based Rna Sequencing Market, By End User
9.1 Introduction
9.2 Research Centers And Academic & Government Institutes
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 Global Ngs-based Rna Sequencing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia-pacific
10.5 Rest Of The World
11 Competitive Landscape
11.1 Business Overview
11.2 Vendor Inclusion Criteria
11.3 Vendor Dive
11.3.1 Vanguards
11.3.2 Innovators
11.3.3 Dynamic Players
11.3.4 Emerging Players
?
11.4 Competitive Benchmarking
11.4.1 Product Offering (For All 25 Companies)
11.4.2 Business Strategy (For All 25 Companies)
*Top 25 Companies Analyzed For This Study Are - Illumina, Inc. (U.S.), Thermo Fisher Scientific (U.S.), Pacific Biosciences Of California, Inc. (U.S.), Oxford Nanopore Technologies (U.K.), Perkinelmer, Inc. , (U.S.), Qaigen N.V. (Germany), F. Hoffmann-la Roche Ag (Switzerland), Agilent Technologies (U.S.), Bio-rad Laboratories, Inc. (U.S.), Gatc Biotech Ag (Germany), Macrogen, Inc. (South Korea), Eurofins Scientific (Luxembourg), Bgi (China), Takara Holdings Inc. (Japan), Cofactor Genomics, Inc. (U.S.), Otogenetics Corporation (U.S.), Nugen Technologies Inc. (U.S.), Hamilton Company (U.S.), Intrexon Corp. (U.S.), 10x Genomics, Inc. (U.S.), Personalis Inc. (U.S.), Genewiz, Inc. (U.S.), Medgenome Inc. (U.S.), Novogene Corporation (China), And Biomatters Ltd. (New Zealand)
12 Company Profiles
(Overview, Products And Services, Financials, Strategy & Development)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific Inc.
12.3 Pacific Biosciences Of California, Inc.
12.4 Qaigen N.V.
12.5 F. Hoffmann-la Roche Ag
12.6 Agilent Technologies, Inc.
12.7 Bgi (Beijing Genomics Institute)
12.8 Oxford Nanopore Technologies, Ltd
12.9 Perkinelmer, Inc.
12.10 Eurofins Scientific
12.11 Gatc Biotech Ag
12.12 Macrogen, Inc.
*Details On Overview, Products And Services, Financials, Strategy & Development Might Not Be Captured In Case Of Unlisted Companies.